Paul A. Kramer
- Molecular Biology
- Pharmaceutical Science top 5%
- Biomaterials
- Pharmacology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Craig J. McClainTing‐Kai LiBertil GladerDane O. KildsigGilbert S. BankerDennis J. ChapronT. Burnstein
- Topics
- Pharmacogenetics and Drug Metabolism (3 papers)Chemical Synthesis and Analysis (2 papers)Amino Acid Enzymes and Metabolism (2 papers)
- Partner nations
- United States
In The Last Decade
Paul A. Kramer
11 papers receiving 374 citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 131
- Pharmaceutical Science 113
- Biomaterials 83
- Pharmacology 58
- Pulmonary and Respiratory Medicine 43
Countries citing papers authored by Paul A. Kramer
This map shows the geographic impact of Paul A. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Kramer more than expected).
Fields of papers citing papers by Paul A. Kramer
This network shows the impact of papers produced by Paul A. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Kramer. The network helps show where Paul A. Kramer may publish in the future.
Co-authorship network of co-authors of Paul A. Kramer
This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Kramer. A scholar is included among the top collaborators of Paul A. Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Kramer. Paul A. Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 70 | |
| 3 | 33 | |
| 4 | 2 | |
| 5 | 15 | |
| 6 | 24 | |
| 7 | 52 | |
| 8 | 4 | |
| 9 | 154 | |
| 10 | 4 | |
| 11 | 61 |
About Paul A. Kramer
Paul A. Kramer is a scholar working on Biochemistry, Pharmacology and Pharmaceutical Science, having authored 11 papers that have together received 422 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Chemical Synthesis and Analysis (2 papers) and Amino Acid Enzymes and Metabolism (2 papers). The work is most often cited by research in Pharmaceutical Science (113 citations), Pharmacology (58 citations) and Biomaterials (83 citations). Paul A. Kramer has collaborated with scholars based in United States. Frequent co-authors include Craig J. McClain, Ting‐Kai Li, Bertil Glader, Dane O. Kildsig, Gilbert S. Banker, Dennis J. Chapron and T. Burnstein. Their work appears in journals such as New England Journal of Medicine, Biochemical Pharmacology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.